Face lift – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 11:28:23 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Face lift – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on the Effectiveness of Clostridium Botulinum Neurotoxin Type A for Reducing Wrinkles in Adults https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-clostridium-botulinum-neurotoxin-type-a-for-reducing-wrinkles-in-adults/ Wed, 29 Apr 2026 15:05:46 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-clostridium-botulinum-neurotoxin-type-a-for-reducing-wrinkles-in-adults/ This clinical trial is focused on studying the effects of a treatment for wrinkles and fine lines on the face. The treatment being tested is called Bocouture, which contains a substance known as Clostridium botulinum neurotoxin type A. This substance is commonly used in cosmetic procedures to reduce the appearance of wrinkles by temporarily relaxing the muscles.

The purpose of the study is to evaluate how satisfied participants are with the results of the treatment. Participants will receive either the actual treatment or a placebo, which is a substance with no active ingredients. The study will compare the satisfaction levels of those who receive the treatment with those who receive the placebo. The treatment will be administered in split doses, meaning it will be given in smaller amounts but more frequently than usual.

Participants will be involved in the study for a period of time, during which they will receive the treatment and attend follow-up visits. The main focus will be on the change in satisfaction from the beginning of the study to two months after the last treatment. The study will also monitor any adverse events, which are any unexpected or negative reactions to the treatment. The goal is to understand the overall satisfaction with the treatment and its safety.

]]> Study on the Effects of Botulinum Toxin Type A for Treating Moderate to Severe Forehead Lines in Adults https://clinicaltrials.eu/trial/study-on-the-effects-of-botulinum-toxin-type-a-for-treating-moderate-to-severe-forehead-lines-in-adults/ Wed, 29 Apr 2026 14:23:04 +0000 https://clinicaltrials.eu/trial/study-on-the-effects-of-botulinum-toxin-type-a-for-treating-moderate-to-severe-forehead-lines-in-adults/ This clinical trial is focused on studying the treatment of moderate and severe horizontal forehead lines, which are the lines that appear on the forehead when raising the eyebrows. The treatment being tested is called LetibotulinumtoxinA, a form of botulinum toxin type A, commonly used to relax muscles. The study will compare the effects of three different dosages of this treatment to see how well they work and how safe they are.

The purpose of the study is to assess how effective and safe these different dosages are in reducing forehead lines. Participants will receive the treatment through an injection into the muscles of the forehead. The study will be conducted over several months, with participants attending multiple visits to monitor their progress. During these visits, the improvement in forehead lines will be evaluated by a specialist who does not know which dosage the participant received. Participants will also be asked about their satisfaction with the treatment and any changes they notice in their appearance.

The study aims to provide valuable information on the best dosage of LetibotulinumtoxinA for treating forehead lines, helping to improve the appearance of these lines safely and effectively. Participants will be monitored closely throughout the study to ensure their well-being and to gather comprehensive data on the treatment’s effects.

]]>